At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRE Prenetics Global
Trading 05-23 11:52:43 EDT
5.91
+0.11
+1.86%
High5.91
Low5.91
Vol322.00
Open5.91
D1 Closing5.80
Amplitude0.03%
Mkt Cap72.18M
Tradable Cap47.14M
Total Shares12.22M
T/O1.90K
T/O Rate0.00%
Tradable Shares7.98M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Fundamental Global Inc. 8.00% CUM PRE STK SERIES A declares $0.50 dividend
BRAGG PRE-ANNOUNCES FULL YEAR 2023 REVENUE RISE OF 10.4% TO EUR 93.5 MILLION (USD 100.5 MILLION) AND ADJUSTED EBITDA GROWTH OF 26.3% TO EUR 15.2 MILLION (USD 16.3 MILLION)
UNCLE NEAREST CEO FAWN WEAVER'S "LOVE & WHISKEY" SHATTERS PRE-PUBLICATION SALES EXPECTATIONS, ECLIPSING NATIONAL BESTSELLERS FOUR MONTHS AHEAD OF RELEASE
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.